Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

RecruitingOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Migraine
Trial Locations (10)

T3M 1M4

RECRUITING

Calgary Headache Assessment and Management Program /ID# 271475, Calgary

V6Z 2E8

RECRUITING

Dr May Ong INC /ID# 271474, Vancouver

B3R 1V9

RECRUITING

Maritime Neurology /ID# 271867, Halifax

K7M 8H9

RECRUITING

Neurocentre of Eastern Ontario /ID# 271865, Kingston

N6A 2C2

RECRUITING

Centricity /ID# 271477, London

N6A 5W9

RECRUITING

London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 272031, London

K1H 7X7

RECRUITING

360 Concussion Care /ID# 271972, Ottawa

G6W 0M5

RECRUITING

Centre de Recherche St-Louis /ID# 272843, Lévis

H4A 3T2

RECRUITING

Genge Partners /ID# 273302, Montreal

J1L 0H8

RECRUITING

Diex Recherche Sherbrooke /ID# 271677, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY